Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valvanera Vozmediano

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 30, 2019
Hartmut Derendorf's work on tissue distributionValvanera Vozmediano, Markus Müller, Stephan Schmidt
Journal of Clinical Pharmacology|May 16, 2019
Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution: A Metoprolol Extended-Release Case StudyJoshua D Brown, Carl Henriksen, Valvanera Vozmediano, et al.
Pharmaceutical Research|October 4, 2017
Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study DesignValvanera Vozmediano, Ander Sologuren, John C Lukas, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 16, 2017
Genotype-guided dosing of warfarin through modeling and simulationJiexin Deng, Valvanera Vozmediano, Monica Rodriguez, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 14, 2023
PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida aurisUnai Caballero, Elena Eraso, Guillermo Quindós, et al.
Journal of Clinical Pharmacology|May 18, 2019
Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of AcetaminophenSibo Jiang, Valvanera Vozmediano, Susan M Abdel-Rahman, et al.
Journal of Pharmaceutical Sciences|September 21, 2019
Integrating Drug- and Formulation-Related Properties With Gastrointestinal Tract Variability Using a Product-Specific Particle Size Approach: Case Example IbuprofenRodrigo Cristofoletti, Bart Hens, Nikunjkumar Patel, et al.
Paediatric Drugs|May 10, 2013
A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approachEsther Encinas, Rosario Calvo, John C Lukas, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 27, 2013
Integration of preclinical and clinical knowledge to predict intravenous PK in human: bilastine case studyValvanera Vozmediano, Ignacio Ortega, John C Lukas, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic VariabilityOskar Estradé, Valvanera Vozmediano, Nerea Carral, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 30, 2019
Hartmut Derendorf's work on tissue distributionValvanera Vozmediano, Markus Müller, Stephan Schmidt
Journal of Clinical Pharmacology|May 16, 2019
Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution: A Metoprolol Extended-Release Case StudyJoshua D Brown, Carl Henriksen, Valvanera Vozmediano, et al.
Pharmaceutical Research|October 4, 2017
Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study DesignValvanera Vozmediano, Ander Sologuren, John C Lukas, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 16, 2017
Genotype-guided dosing of warfarin through modeling and simulationJiexin Deng, Valvanera Vozmediano, Monica Rodriguez, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 14, 2023
PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida aurisUnai Caballero, Elena Eraso, Guillermo Quindós, et al.
Journal of Clinical Pharmacology|May 18, 2019
Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of AcetaminophenSibo Jiang, Valvanera Vozmediano, Susan M Abdel-Rahman, et al.
Journal of Pharmaceutical Sciences|September 21, 2019
Integrating Drug- and Formulation-Related Properties With Gastrointestinal Tract Variability Using a Product-Specific Particle Size Approach: Case Example IbuprofenRodrigo Cristofoletti, Bart Hens, Nikunjkumar Patel, et al.
Paediatric Drugs|May 10, 2013
A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approachEsther Encinas, Rosario Calvo, John C Lukas, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 27, 2013
Integration of preclinical and clinical knowledge to predict intravenous PK in human: bilastine case studyValvanera Vozmediano, Ignacio Ortega, John C Lukas, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic VariabilityOskar Estradé, Valvanera Vozmediano, Nerea Carral, et al.
Pageof 5